Back
Phathom Pharmaceuticals, Inc. 10K Form
Sell
37
PHAT
Phathom Pharmaceuticals, Inc.
Last Price:
$14.70
Seasonality Move:
-8.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAT News And Ratings
See the #1 stock for the next 7 days that we like better than PHAT
PHAT Financial Statistics
Sales & Book Value
| Annual Sales: | $55.3M |
|---|---|
| Cash Flow: | $-14.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-5.95 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.81290 |
|---|---|
| Net Income (TTM): | $-274.6M |
| Gross Margin: | $47.3M |
| Return on Equity: | 0% |
| Return on Assets: | -88.55% |
Phathom Pharmaceuticals, Inc. Earnings Forecast
Key Phathom Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for PHAT is 85.57%.
-
The Selling, General & Administrative Expenses for PHAT have been equal to 526.07% of Gross Profit Margin.
-
The Research & Development expenses have been 61.68% of Revenue.
-
The Net Earning history of PHAT is -605.09% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Phathom Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PHAT |
| CUSIP: | 71722W |
| Website: | phathompharma.com |
Debt
| Debt-to-Equity Ratio: | -1.38 |
|---|---|
| Current Ratio: | 2.23 |
| Quick Ratio: | 2.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PHAT Technical Analysis vs Fundamental Analysis
Sell
37
Phathom Pharmaceuticals, Inc. (PHAT)
is a Sell
Is Phathom Pharmaceuticals, Inc. a Buy or a Sell?
-
Phathom Pharmaceuticals, Inc. stock is rated a SellThe current Phathom Pharmaceuticals, Inc. [PHAT] share price is $14.56. The Score for PHAT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.